Persistent Systems
Latest news, explainers and analysis on Persistent Systems. Tracking 4 stories on Arth Vani.
Connected in the graph
Latest on Persistent Systems
BreakingPersistent Systems Q2 FY27 Revenue Soars 20% to $487.6M, Acquires Nagarro Stake
Persistent Systems reported strong Q2 FY2027 financial results, with revenue reaching $487.6 million, an impressive 20% increase year-on-year. Simultaneously, the company confirmed its acquisition of approximately 94.04% of Nagarro's share capital and voting rights, marking a significant strategic expansion.
Persistent Systems Shares Plunge on €1.27 Billion Nagarro Acquisition News
Persistent Systems' shares saw a significant drop of nearly 11% after the company announced its plan to acquire Germany-based Nagarro for €1.27 billion. While the deal aims to strengthen Persistent's presence in Europe and boost its revenue, market experts have raised flags over the high valuation and potential challenges in integrating the new business.
Persistent's ₹10,790 Crore European Bet: Immediate Hurdles, Future Aspirations
Indian IT firm Persistent Systems is acquiring European company Nagarro SE for US$1.3 billion (approximately ₹10,790 crore), a move designed to boost its presence in Europe and reduce its reliance on the US market. While this strategy offers long-term benefits, the debt-funded deal, coupled with Nagarro's slowing growth and a high acquisition price, presents significant short-term financial challenges for Persistent. The company now faces the critical task of integrating Nagarro and driving combined revenue growth without compromising its overall profitability.
Persistent Systems Rises on Strong Order Book Amid AI-Led Revenue Concerns
Shares of Persistent Systems are gaining momentum as a robust order book and AI advancements fuel investor optimism. However, analysts warn of a potential revenue slowdown as clients shift their spending patterns to integrate new technologies.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.